Chunxia Du

机构：Shanghai University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research, Lanzhou University · ORCID：0000-0003-3457-6377

发表论文 36 篇 · 总被引 893 次 · h-index 11

代表论文

• Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors (2016 · Journal of Hematology & Oncology · 被引 433)
• Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum (2018 · Clinical Gastroenterology and Hepatology · 被引 120)
• The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome (2018 · American Journal Of Pathology · 被引 83)
• An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer (2020 · British Journal of Cancer · 被引 39)
• Aspirin exerts high anti-cancer activity in PIK3CA -mutant colon cancer cells (2017 · Oncotarget · 被引 30)
• Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial (2024 · Gastric Cancer · 被引 22)